Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data.

Crawford F, Nicolson DJ, Amanna AE, Martin A, Gupta S, Leese GP, Heggie R, Chappell FM, McIntosh HH.

Diabetologia. 2020 Jan;63(1):49-64. doi: 10.1007/s00125-019-05020-7. Epub 2019 Nov 27. Review.

PMID:
31773194
2.

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.

Ochs A, McGurnaghan S, Black MW, Leese GP, Philip S, Sattar N, Styles C, Wild SH, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group and the Diabetic Retinopathy Screening Collaborative.

PLoS Med. 2019 Oct 17;16(10):e1002945. doi: 10.1371/journal.pmed.1002945. eCollection 2019 Oct.

3.

Glycaemic control trends in people with type 1 diabetes in Scotland 2004-2016.

Mair C, Wulaningsih W, Jeyam A, McGurnaghan S, Blackbourn L, Kennon B, Leese G, Lindsay R, McCrimmon RJ, McKnight J, Petrie JR, Sattar N, Wild SH, Conway N, Craigie I, Robertson K, Bath L, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network (SDRN) Epidemiology Group.

Diabetologia. 2019 Aug;62(8):1375-1384. doi: 10.1007/s00125-019-4900-7. Epub 2019 May 18.

4.

The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study.

McGurnaghan SJ, Brierley L, Caparrotta TM, McKeigue PM, Blackbourn LAK, Wild SH, Leese GP, McCrimmon RJ, McKnight JA, Pearson ER, Petrie JR, Sattar N, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group.

Diabetologia. 2019 Apr;62(4):621-632. doi: 10.1007/s00125-018-4806-9. Epub 2019 Jan 10.

PMID:
30631892
5.

Xanthomatous hypophysitis causing hypogonadotropic hypogonadism resulting in delayed presentation of slipped capital femoral epiphysis.

Singh K, Kanodia AK, Ross P, Torgersen A, Maclean J, Leese G, Hossain-Ibrahim K.

Br J Neurosurg. 2018 Nov 19:1-4. doi: 10.1080/02688697.2018.1525482. [Epub ahead of print]

PMID:
30450996
6.

Increased mortality and morbidity in patients with chronic hypoparathyroidism: A population-based study.

Vadiveloo T, Donnan PT, Leese CJ, Abraham KJ, Leese GP.

Clin Endocrinol (Oxf). 2019 Feb;90(2):285-292. doi: 10.1111/cen.13895. Epub 2018 Nov 20.

PMID:
30375660
7.

Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study.

Vadiveloo T, Jeffcoate W, Donnan PT, Colhoun HC, McGurnaghan S, Wild S, McCrimmon R, Leese GP; Scottish Diabetes Research Network Epidemiology Group.

Diabetologia. 2018 Dec;61(12):2590-2597. doi: 10.1007/s00125-018-4723-y. Epub 2018 Aug 31.

8.

In response to: 'Thyroid hormone replacement - a counterblast to guidelines'.

Leese GP, Flynn RV, MacDonald TM, Schofield C, Mackie AD.

J R Coll Physicians Edinb. 2018 Mar;48(1):93. doi: 10.4997/JRCPE.2018.120. No abstract available.

PMID:
29741539
9.

Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study.

Edmonds ME, Bodansky HJ, Boulton AJM, Chadwick PJ, Dang CN, D'Costa R, Johnston A, Kennon B, Leese G, Rajbhandari SM, Serena TE, Young MJ, Stewart JE, Tucker AT, Carter MJ.

Wound Repair Regen. 2018 Mar;26(2):228-237. doi: 10.1111/wrr.12630. Epub 2018 Jul 17.

PMID:
29617058
10.

Attitudes and perceptions of health professionals towards management of hypothyroidism in general practice: a qualitative interview study.

Dew R, King K, Okosieme OE, Pearce SH, Donovan G, Taylor PN, Hickey J, Dayan CM, Leese G, Razvi S, Wilkes S.

BMJ Open. 2018 Feb 21;8(2):e019970. doi: 10.1136/bmjopen-2017-019970.

11.

Diabetes and pregnancy: national trends over a 15 year period.

Mackin ST, Nelson SM, Kerssens JJ, Wood R, Wild S, Colhoun HM, Leese GP, Philip S, Lindsay RS; SDRN Epidemiology Group.

Diabetologia. 2018 May;61(5):1081-1088. doi: 10.1007/s00125-017-4529-3. Epub 2018 Jan 11.

12.

A Population-Based Study of the Epidemiology of Chronic Hypoparathyroidism.

Vadiveloo T, Donnan PT, Leese GP.

J Bone Miner Res. 2018 Mar;33(3):478-485. doi: 10.1002/jbmr.3329. Epub 2017 Nov 30.

13.

Incident ischaemic stroke and Type 2 diabetes: trends in incidence and case fatality in Scotland 2004-2013.

Read SH, McAllister DA, Colhoun HM, Farran B, Fischbacher C, Kerssens JJ, Leese GP, Lindsay RS, McCrimmon RJ, McGurnaghan S, Philip S, Sattar N, Wild SH; Scottish Diabetes Research Network Epidemiology Group.

Diabet Med. 2018 Jan;35(1):99-106. doi: 10.1111/dme.13528. Epub 2017 Nov 6.

PMID:
29044687
14.

Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS).

Hébert HL, Shepherd B, Milburn K, Veluchamy A, Meng W, Carr F, Donnelly LA, Tavendale R, Leese G, Colhoun HM, Dow E, Morris AD, Doney AS, Lang CC, Pearson ER, Smith BH, Palmer CNA.

Int J Epidemiol. 2018 Apr 1;47(2):380-381j. doi: 10.1093/ije/dyx140. No abstract available.

15.

Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study.

Soto-Pedre E, Newey PJ, Bevan JS, Leese GP.

Endocr Connect. 2017 Nov;6(8):580-588. doi: 10.1530/EC-17-0171.

16.

Diabetic foot infection: Antibiotic therapy and good practice recommendations.

Barwell ND, Devers MC, Kennon B, Hopkinson HE, McDougall C, Young MJ, Robertson HMA, Stang D, Dancer SJ, Seaton A, Leese GP; Scottish Diabetes Foot Action Group.

Int J Clin Pract. 2017 Oct;71(10). doi: 10.1111/ijcp.13006. Epub 2017 Sep 11.

PMID:
28892282
17.

Temporal changes in frequency of severe hypoglycemia treated by emergency medical services in types 1 and 2 diabetes: a population-based data-linkage cohort study.

Wang H, Donnan PT, Leese CJ, Duncan E, Fitzpatrick D, Frier BM, Leese GP.

Clin Diabetes Endocrinol. 2017 Aug 15;3:7. doi: 10.1186/s40842-017-0045-0. eCollection 2017.

18.

Replication confirms the association of loci in FOXE1, PDE8B, CAPZB and PDE10A with thyroid traits: a Genetics of Diabetes Audit and Research Tayside study (GoDARTS).

Soto-Pedre E, Siddiqui MK, Doney AS, Palmer CNA, Pearson ER, Leese GP.

Pharmacogenet Genomics. 2017 Oct;27(10):356-362. doi: 10.1097/FPC.0000000000000299.

PMID:
28727628
19.

Interaction between variants in the CYP2C9 and POR genes and the risk of sulfonylurea-induced hypoglycaemia: A GoDARTS Study.

Dujic T, Zhou K, Donnelly LA, Leese G, Palmer CNA, Pearson ER.

Diabetes Obes Metab. 2018 Jan;20(1):211-214. doi: 10.1111/dom.13046. Epub 2017 Aug 25.

20.

Patients' attitudes and perceptions towards treatment of hypothyroidism in general practice: an in-depth qualitative interview study.

Dew R, King K, Okosieme OE, Pearce S, Donovan G, Taylor P, Leese G, Hickey J, Razvi S, Dayan C, Wilkes S.

BJGP Open. 2017 Jun 28;1(2):bjgpopen17X100977. doi: 10.3399/bjgpopen17X100977.

21.

Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.

Bell S, Farran B, McGurnaghan S, McCrimmon RJ, Leese GP, Petrie JR, McKeigue P, Sattar N, Wild S, McKnight J, Lindsay R, Colhoun HM, Looker H.

BMC Nephrol. 2017 May 19;18(1):163. doi: 10.1186/s12882-017-0579-5.

22.

Anabolic resistance does not explain sarcopenia in patients with type 2 diabetes mellitus, compared with healthy controls, despite reduced mTOR pathway activity.

Cuthbertson DJ, Babraj J, Leese G, Siervo M.

Clin Nutr. 2017 Dec;36(6):1716-1719. doi: 10.1016/j.clnu.2016.11.012. Epub 2016 Nov 25.

PMID:
28017449
23.

Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.

Scanlon PH, Stratton IM, Bachmann MO, Jones C, Leese GP; Four Nations Diabetic Retinopathy Screening Study Group.

Diabet Med. 2016 Dec;33(12):1655-1658. doi: 10.1111/dme.13263. Epub 2016 Oct 19.

24.

The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS).

Soto-Pedre E, Newey PJ, Bevan JS, Greig N, Leese GP.

Clin Endocrinol (Oxf). 2017 Jan;86(1):60-67. doi: 10.1111/cen.13156. Epub 2016 Sep 7.

PMID:
27434534
25.

CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes.

Dawed AY, Donnelly L, Tavendale R, Carr F, Leese G, Palmer CN, Pearson ER, Zhou K.

Diabetes Care. 2016 Nov;39(11):1902-1908. Epub 2016 Jun 6.

PMID:
27271184
26.

Thyroxine replacement: a clinical endocrinologist's viewpoint.

Eligar V, Taylor PN, Okosieme OE, Leese GP, Dayan CM.

Ann Clin Biochem. 2016 Jul;53(Pt 4):421-33. doi: 10.1177/0004563216642255. Epub 2016 Apr 28. Review.

PMID:
27126268
27.

Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.

Scotland G, McKeigue P, Philip S, Leese GP, Olson JA, Looker HC, Colhoun HM, Javanbakht M.

Diabet Med. 2016 Jul;33(7):886-95. doi: 10.1111/dme.13129. Epub 2016 May 11.

PMID:
27040994
28.

An audit of the management of childhood-onset growth hormone deficiency during young adulthood in Scotland.

Ahmid M, Fisher V, Graveling AJ, McGeoch S, McNeil E, Roach J, Bevan JS, Bath L, Donaldson M, Leese G, Mason A, Perry CG, Zammitt NN, Ahmed SF, Shaikh MG.

Int J Pediatr Endocrinol. 2016;2016:6. doi: 10.1186/s13633-016-0024-8. Epub 2016 Mar 16.

29.

Liothyronine use in a 17 year observational population-based study - the tears study.

Leese GP, Soto-Pedre E, Donnelly LA.

Clin Endocrinol (Oxf). 2016 Dec;85(6):918-925. doi: 10.1111/cen.13052. Epub 2016 Mar 21.

PMID:
26940864
30.

Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study.

Wake DJ, Broughton P, Perera SM, MacIntyre DJ, Leese GP.

Psychoneuroendocrinology. 2016 Apr;66:214-20. doi: 10.1016/j.psyneuen.2016.01.022. Epub 2016 Jan 23.

PMID:
26849203
31.

Core Standards of the EUBIROD Project. Defining a European Diabetes Data Dictionary for Clinical Audit and Healthcare Delivery.

Cunningham SG, Carinci F, Brillante M, Leese GP, McAlpine RR, Azzopardi J, Beck P, Bratina N, Bocquet V, Doggen K, Jarosz-Chobot PK, Jecht M, Lindblad U, Moulton T, Metelko Ž, Nagy A, Olympios G, Pruna S, Skeie S, Storms F, Di Iorio CT, Massi Benedetti M.

Methods Inf Med. 2016;55(2):166-76. doi: 10.3414/ME15-01-0016. Epub 2015 Dec 15.

PMID:
26666452
32.

Response to Comment on Leese et al. Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals. Diabetes Care 2015;38:488-494.

Leese GP, Stratton IM, Land M, Bachmann MO, Jones C, Scanlon P, Looker HC, Ferguson B; Four Nations Diabetic Retinopathy Screening Study Group.

Diabetes Care. 2015 Dec;38(12):e209-10. doi: 10.2337/dci15-0015. No abstract available.

PMID:
26604286
33.

When and how to audit a diabetic foot service.

Leese GP, Stang D.

Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:311-7. doi: 10.1002/dmrr.2749.

PMID:
26452683
34.

Pre-operative serum alkaline phosphatase as a predictive indicator of post-operative hypocalcaemia in patients undergoing total thyroidectomy.

Miah MS, Mahendran S, Mak C, Leese G, Smith D.

J Laryngol Otol. 2015 Nov;129(11):1128-32. doi: 10.1017/S0022215115002352. Epub 2015 Sep 29.

PMID:
26415610
35.

The risk of total mortality and cardiovascular mortality associated with impaired glucose regulation in Tayside, Scotland, UK: a record-linkage study in 214 094 people.

Evans JM, Eades CE, Leese GP.

BMJ Open Diabetes Res Care. 2015 Sep 16;3(1):e000102. doi: 10.1136/bmjdrc-2015-000102. eCollection 2015.

36.

Screening attendance, age group and diabetic retinopathy level at first screen.

Scanlon PH, Stratton IM, Leese GP, Bachmann MO, Land M, Jones C, Ferguson B; Four Nations Diabetic Retinopathy Screening Study Group.

Diabet Med. 2016 Jul;33(7):904-11. doi: 10.1111/dme.12957. Epub 2015 Oct 6.

37.

Association between retinal vasculature and muscle mass in older people.

Sumukadas D, McMurdo M, Pieretti I, Ballerini L, Price R, Wilson P, Doney A, Leese G, Trucco E.

Arch Gerontol Geriatr. 2015 Nov-Dec;61(3):425-8. doi: 10.1016/j.archger.2015.08.006. Epub 2015 Aug 4.

PMID:
26276247
38.

Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee.

Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M, Leese G, McCabe C, Perros P, Smith V, Williams G, Vanderpump M.

Clin Endocrinol (Oxf). 2016 Jun;84(6):799-808. doi: 10.1111/cen.12824. Epub 2015 Jun 25. Review.

39.

Asymptomatic and mild primary hyperparathyroidism.

Macfarlane DP, Yu N, Leese GP.

Ann Endocrinol (Paris). 2015 May;76(2):120-7. doi: 10.1016/j.ando.2015.03.001. Epub 2015 Apr 14. Review.

PMID:
25882891
40.

The Authors' Reply: Statins and thyroid-stimulating hormone.

Leese G.

Clin Endocrinol (Oxf). 2015 Nov;83(5):747-8. doi: 10.1111/cen.12757. Epub 2015 Mar 19. No abstract available.

PMID:
25711238
41.

Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland.

Malik MO, Govan L, Petrie JR, Ghouri N, Leese G, Fischbacher C, Colhoun H, Philip S, Wild S, McCrimmon R, Sattar N, Lindsay RS; Scottish Diabetes Research Network Epidemiology Group.

Diabetologia. 2015 Apr;58(4):716-25. doi: 10.1007/s00125-015-3492-0. Epub 2015 Feb 12.

PMID:
25669630
42.

Progression from gestational diabetes to type 2 diabetes in one region of Scotland: an observational follow-up study.

Eades CE, Styles M, Leese GP, Cheyne H, Evans JM.

BMC Pregnancy Childbirth. 2015 Feb 3;15:11. doi: 10.1186/s12884-015-0457-8.

43.

Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010.

Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, Leese G, Leslie P, McCrimmon RJ, Metcalfe W, McKnight JA, Morris AD, Pearson DW, Petrie JR, Philip S, Sattar NA, Traynor JP, Colhoun HM; Scottish Diabetes Research Network epidemiology group; Scottish Renal Registry.

JAMA. 2015 Jan 6;313(1):37-44. doi: 10.1001/jama.2014.16425.

44.

Progression of diabetes retinal status within community screening programs and potential implications for screening intervals.

Leese GP, Stratton IM, Land M, Bachmann MO, Jones C, Scanlon P, Looker HC, Ferguson B; Four Nations Diabetic Retinopathy Screening Study Group.

Diabetes Care. 2015 Mar;38(3):488-94. doi: 10.2337/dc14-1778. Epub 2014 Dec 18.

PMID:
25524948
45.

End-stage renal disease and survival in people with diabetes: a national database linkage study.

Bell S, Fletcher EH, Brady I, Looker HC, Levin D, Joss N, Traynor JP, Metcalfe W, Conway B, Livingstone S, Leese G, Philip S, Wild S, Halbesma N, Sattar N, Lindsay RS, McKnight J, Pearson D, Colhoun HM; Scottish Diabetes Research Network and Scottish Renal Registry.

QJM. 2015 Feb;108(2):127-34. doi: 10.1093/qjmed/hcu170. Epub 2014 Aug 19.

46.

Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS).

Irving SA, Vadiveloo T, Leese GP.

Clin Endocrinol (Oxf). 2015 Jan;82(1):136-41. doi: 10.1111/cen.12559. Epub 2014 Aug 14.

PMID:
25040647
47.

Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK study.

Prescott G, Sharp P, Goatman K, Scotland G, Fleming A, Philip S, Staff R, Santiago C, Borooah S, Broadbent D, Chong V, Dodson P, Harding S, Leese G, Megaw R, Styles C, Swa K, Wharton H, Olson J.

Br J Ophthalmol. 2014 Aug;98(8):1042-9. doi: 10.1136/bjophthalmol-2013-304338. Epub 2014 Mar 28.

PMID:
24682180
48.

Subclinical and asymptomatic parathyroid disease: implications of emerging data.

Macfarlane DP, Yu N, Leese GP.

Lancet Diabetes Endocrinol. 2013 Dec;1(4):329-40. doi: 10.1016/S2213-8587(13)70083-4. Epub 2013 Oct 24. Review.

PMID:
24622418
49.

Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme.

Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Black MW, Doig J, Lee N, Lindsay RS, McKnight JA, Morris AD, Pearson DW, Philip S, Wild SH, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group; Scottish Diabetic Retinopathy Collaborative.

Br J Ophthalmol. 2014 Jun;98(6):790-5. doi: 10.1136/bjophthalmol-2013-303948. Epub 2014 Mar 5.

50.

Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008.

Jones NR, Fischbacher CM, Guthrie B, Leese G, Lindsay RS, McKnight JA, Pearson D, Philip S, Sattar N, Wild SH; Scottish Diabetes Research Network Epidemiology Group.

Diabet Med. 2014 Jun;31(6):640-6. doi: 10.1111/dme.12409. Epub 2014 Mar 24.

Supplemental Content

Support Center